Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

ENETS Abstract Search

#4288 A virtual patient handbook

Introduction: Neuroendocrine cancer has lower public recognition than more common cancer types and when this is combined with geographical inequalities in neuroendocrine cancer care across the UK, patients can often find themselves reliant on online resources to educate themselves about the disease.

Conference:

Presenting Author:

Authors: Chesser B,

Keywords: patient handbook, digital resources, patient information, multi-media,

#3718 Epidemiology of neuroendocrine neoplasms (NEN) in England 2012-2018 – Home location, incidence and survival including access to neuroendocrine centres of excellence (CoE)

Introduction: Many cancers have been associated with environmental factors but these remain unexplored for NEN. Travel to and from a CoE can be a significant burden to patients. There is evidence that this impacts on treatment outcomes and survival in other cancers.

Conference:

Presenting Author: Nwoguh C

Authors: Nwoguh C, Chandrakumaran K, White B, Russell B, Handford J,

Keywords: neuroendocrine, access to care, neuroendocrine neoplasm, incidence, geospatial, mapping, geographic, survival, environmental factors,

#3557 Final analysis of Chromogranin A for neuroendocrine tumor diagnosis in Chilean patients: An updated case-control study

Introduction: Neuroendocrine tumors (NETs) are highly heterogeneous and differ geographically. Serum chromogranin A (CgA) is the most used biomarker for NET diagnosis, with a sensitivity of 63-100% and specificity of 95-98% with a cutoff value of 108 ng/mL. Recent studies worldwide have reported varying frequencies of NET patients with high CGA at diagnosis, suggesting that the cutoff value may differ according to each population.

Conference:

Presenting Author: Muñoz Medel M

Authors: Muñoz Medel M, Cordova Delgado M, Duran D, Pinto M, Bravo M,

Keywords: neuroendocrine, chromogranin a, biomarker,

#3522 Clinical epidemiology of upper gastrointestinal neuroendocrine neoplasms (UGI-NENs): A nationwide multi-center 10-year retrospective study

Introduction: The upper gastrointestinal neuroendocrine neoplasms (UGI-NEN) are the most common endocrine neoplasms (NEN), and the incidence has increased rapidly in recent years.

Conference:

Presenting Author: Wang X

Authors: Wang X, Yang H, Chi Y, Fan J,

Keywords: upper gastrointestinal neuroendocrine neoplasm, retrospective study, multi-center, clinical epidemiology,

#3356 Association between age of initial diagnosis and prognosis of gastroenteropancreatic neuroendocrine neoplasms:A nation-wide 10-year retrospective clinical epidemiological study in China

Introduction: Previous research on the association between age of initial diagnosis and prognosis of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) is rare in China.

Conference:

Presenting Author: Yang Huan H

Authors: Yang H, Jiang L, Shi S, Yihebali C, Fan J,

Keywords: age of initial diagnosis, gastroenteropancreatic neuroendocrine neoplasm, clinicopathological characteristics, treatment, prognosis,